EPW
BMY icon

Evolve Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Evolve Private Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.75M Sell
99,797
-3,837
-4% -$220K 0.35% 47
2026
Q1 		$6.29M Buy
103,634
+1,396
+1% +$81.4K 0.34% 47
2025
Q4 		$5.51M Buy
+102,238
New +$4.92M 0.33% 51

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Evolve Private Wealth's BMY Position: Q2 2026 in Review

Evolve Private Wealth reduced its Bristol-Myers Squibb (BMY) stake by 3.7% in Q2 2026, selling an estimated $220K and leaving 99,797 shares worth $5.75M. The position accounts for 0.35% of the portfolio, ranked #47.

Evolve Private Wealth first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.29M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Evolve Private Wealth held 99,797 shares of Bristol-Myers Squibb worth $5.75M as of Q2 2026.
  • Evolve Private Wealth sold 3,837 Bristol-Myers Squibb shares in Q2 2026, an estimated $220K.
  • Bristol-Myers Squibb made up 0.35% of Evolve Private Wealth's portfolio in Q2 2026, its #47 holding.
  • Evolve Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's Bristol-Myers Squibb position peaked at $6.29M in Q1 2026.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.